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Background: Despite the high mortality rates of HIV and cancer in sub-Saharan Africa, there are few outcome tools
and no comparative data across conditions. This study aimed to measure multidimensional wellbeing among
advanced HIV and/or cancer patients in three African countries, and determine the relationship between two
validated outcome measures.
Methods: Cross-sectional self-reported data from palliative care populations in Kenya, Uganda and South Africa
using FACIT-G+Pal and POS measures.
Results: Among 461 participants across all countries, subscale “social and family wellbeing” had highest (best)
score. Significant country effect showed lower (worse) scores for Uganda on 3 FACIT G subscales: Physical,
Social + family, and functional. In multiple regression, country and functional status accounted for 21% variance in
FACIT-Pal. Worsening functional status was associated with poorer POS score. Kenyans had worse POS score,
followed by Uganda and South Africa. Matrix of correlational coefficients revealed moderate correlation between
the POS and FACIT-Pal core scale (0.60), the FACIT-G and POS (0.64), and FACIT-G + Pal with POS (0.66).
Conclusions: The data reveal best status for family and social wellbeing, which may reflect the sample being from
less individualistic societies. The tools appear to measure different constructs of wellbeing in palliative care, and
reveal different levels of wellbeing between countries. Those with poorest physical function require greatest
palliative and supportive care, and this does not appear to differ according to diagnosis.
Keywords: Sub-Saharan Africa, HIV, Cancer, Palliative care, Outcome, Self-reportBackground
In 2012 an estimated 25 million people in sub-Saharan
Africa lived with HIV infection and there were 1.2
million HIV-related deaths [1]. The most recent esti-
mates for cancer in sub-Saharan Africa suggest in 2012
approximately 591,000 cancer deaths [2]. For people
with life-limiting progressive disease, palliative care is
advocated by the World Health Organization (WHO) as
necessary throughout the disease trajectory, due to the* Correspondence: richard.harding@kcl.ac.uk
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unless otherwise stated.multidimensional (physical, psychological, social and
spiritual) problems that are experienced [3-8]. Despite the
epidemiology of progressive disease in Africa, and the
need to measure multidimensional outcomes for patients
and their families, there has been a dearth of evidence of
patient and family care needs in both HIV and cancer
populations [9,10].
The ability to measure wellbeing among populations
across domains of need is essential for effective palliative
care. However, the development of appropriate clinical
interventions and health systems development is ham-
pered by a lack of locally-generated data. Although some
data have been generated on the needs and symptoms ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ease populations are rarely investigated using locally
well-validated outcome measures. Furthermore, due to
the challenges of opioid prescribing and availability in
Africa, the palliative care research agenda has been dom-
inated by the study of pain and analgesia [11-16], with
less evidence of the needs that constitute the patient
holistic experience of illness. This is especially important
in developing patient-centred care, as previous studies of
patients with advanced disease in sub-Saharan Africa
have highlighted the burden of symptoms, the need for
information, and the importance attached to spiritual
wellbeing [4,5,17,18]. Therefore, the selection of patient-
reported outcome measures (PROMs) that are fit for
purpose and reflect patient concerns is essential in pro-
moting quality and equity [19]. There are currently few
outcome measurement tools that are fit for purpose in
African palliative care populations, i.e. tools that reflect
the domains relevant to patients in Africa with progres-
sive disease in line with the WHO definition of palliative
care [20], and which have been subjected to local valid-
ation. It is currently unclear whether the available tools
measure the same outcomes and underlying concepts.
This study aimed to measure multidimensional well-
being, to identify factors associated with patient wellbeing,
among patients with advanced HIV and/or cancer in three
African countries, and to determine the relationship be-
tween two outcome measures validated in this population.
Method
Design
This international multicentred study used a cross-sectional
self-report design using outcome measures among patients
with incurable, progressive disease in South Africa, Uganda
and Kenya.
Setting
South African data were collected at two palliative care
facilities of similar size and serving communities in
metropolitan areas with a range of socio-economic sta-
tus, including informal settlements. The first hospice has
10 inpatient beds and serves community patients in the
Western Cape Province. The second South African site
is a hospice with an eight-bed inpatient unit and a com-
munity team serving patients in a metropolitan commu-
nity in the Eastern Cape Province. Ugandan data were
collected at a hospice in the capital city that provides
home and day care. Kenyan data were collected from
two sites. The first Kenyan site is a hospice in the capital
city Nairobi, which cares for patients at different points
i.e. at the hospice, home visits, hospital visits and they
have a mobile clinic in one of the largest informal settle-
ments within the city environs. The second Kenyan site
is a rural hospice situated in the Mount Kenya region inCentral Province that operates as a satellite of the capital
city hospice, providing holistic care within the hospice,
day care services, hospital consultations as well as hold-
ing a monthly legal aid clinic. All the participating ser-
vices aim to provide holistic palliative care in line with
the WHO definition [20].
Recruitment
Inclusion criteria were adult patients (at least 18 years old)
with a confirmed HIV and/or cancer diagnosis known to
the patient, under palliative care, with sufficient physical
and cognitive ability to participate in interviews (as deter-
mined by their clinician). Patients were recruited consecu-
tively. All information and consent forms and tools
were translated from English (forward and back) into
the principal languages of isiXhosa, Afrikaans, Kiswahili,
Runyakitara, Luganda, and Kikuyu. Existing FACIT-Pal
translations were used where available from the tool
provider (i.e., the FACT-G in Afrikaans, Kiswahili) [21]. In-
formed consent was obtained from all participants. Transla-
tion was carried out by the collaborating African research
organisations, and crosschecked by staff fluent in both
English and the relevant local language. The study was
reviewed and approved by the Ethical Review Board of the
Hospice Palliative Care Association of South Africa, the
Uganda National Council for Science and Technology,
and the Kenyan Medical Research Institute.
Data collection
The following patient demographic and clinical data were
collected: age (analysed as three levels 18–39, 40–51 and
52–94), gender, primary diagnosis (HIV or cancer), house-
hold size (i.e., number of people in household), number of
children for whom the patient is responsible, and primary
place of palliative care (home, inpatient/outpatient unit,
day care facility). We elected to collect data on the num-
ber of children for whom respondents were responsible,
rather than the number of biological children given that
adults may often care for children other than their own
(e.g., grandchildren, nephews and nieces), a situation which
has been exacerbated by AIDS-related deaths.
The following tools were administered. Functional sta-
tus was measured using the ECOG, a very commonly
used measure of physical function [22,23]. The African
Palliative Care Association African Palliative Outcome
Scale (APCA African POS) was used to measure the three-
day period prevalence and associated burden of multidi-
mensional problems. This tool was developed across eight
sub-Saharan African countries [24] and validated among
682 patients and 437 caregivers [25]. The seven patient-
oriented items address pain, symptoms, worry, sharing
feelings, feeling life is worthwhile, feeling at peace, and help
and advice to plan for the future. The three caregiver-
oriented items address family confidence to care, family
Harding et al. Health and Quality of Life Outcomes 2014, 12:80 Page 3 of 8
http://www.hqlo.com/content/12/1/80information and family worry. Each item is scored on a
scale of 0–5. A stable three factor structure has been iden-
tified [26]. Some item scores were reversed so that for all
items and total score, lower score reflects better problem
intensity, and the potential score range for patient items is
0–35.
The Functional Assessment of Chronic Illness Therapy-
General (FACIT-G) is a 27-item tool that measures the
seven-day period prevalence and intensity of problems
across four primary quality of life domains: Physical well-
being, Social/family well-being, Emotional well-being, and
Functional well-being [27]. It has been used and validated
in chronic conditions, such as HIV. The additional 19
items of the FACIT-PAL module measure palliative care-
related outcomes and are not specific to cancer. The
FACIT-G administered with the FACIT-Pal is referred
here as the FACIT-G + Pal. The FACIT tools have been
globally translated (including into African languages) [28].
A higher score means better status, and the potential
score range for FACIT-G + Pal is 0-184 [29].
Research nurses read out the questionnaire items and
recorded the patient’s self-report response on their be-
half. Self-completion was not used due to potentially
limited respondent literacy, and all questionnaires were
completed using research nurses to record responses.
The selection of a single method (i.e., self-report with re-
search nurse completion) was selected to reduce any po-
tential bias through using a mixture of self-complete and
researcher-completion. Research nurses then entered
data into a purpose-designed Excel database.
Analysis
All statistical analyses were completed using IBM-SPSS-
19. Means, standard deviations and minimum and max-
imum scores were calculated for the FACIT-G total
score, the POS and FACIT-PAL for Kenya, South Africa
and Uganda. Data was analysed according to primary
diagnosis, i.e. those with HIV and cancer were analysed as
HIV due to cancer being a common presentation among
HIV-infected people in Africa. Those analysed as cancer
did not have an HIV diagnosis. Separate one-way analyses
of variance (ANOVA) were used to examine whether
mean scores for FACIT-G, FACIT-Pal and POS were dif-
ferent across the three countries, and MANOVA for the
four subscales of FACIT-G due to their high intercorrel-
ation. Because of the large number of statistical compari-
sons involved, we specified p < 0.01 as the significance
level. A multivariate analysis of variance was then con-
ducted for the four subscales of the FACIT-G to test for
differences across the three samples. T-tests were used to
compare scores on the three measures by gender and
diagnosis (HIV, non-HIV). Univariate and multiple regres-
sion analysis were used to explore the relative contribu-
tions of age (into three equal groups), gender, country,diagnosis and functional status to the dependent variable
of FACIT-G score. FACIT-G scores appeared normally
distributed. All variables were treated as categorical or
dummy variables. Initially each variable was entered indi-
vidually, with those variables significant at the 5% level
entered together into the multivariable model. Finally,
FACIT-G subscales and the FACIT-PAL scale were en-
tered into a correlation matrix with the APCA African
POS total patient score. The correlation coefficient was
Pearson’s r, with the following interpretation: ≤ 0.3 weak,
0.4–0.6 moderate, ≥ 0.7 strong where 0.0 represents no re-
lationship and 1.0 a perfect relationship between two vari-
ables [30].
The sample size provided the following: > 95% power
to detect a moderate effect size (Cohen’s d ≥ 0.5) at the
0.05 significance level in the t-test analyses; for the cor-
relation analyses this sample provided > 95% power to
detect a correlation significantly different from zero at
0.05 significance; for both the univariate and multivariate
regression analyses to provide > 95% power to detect a
medium size effect (Cohen’s f2 ≥ 0.15) at 0.05 significance.
Results
Sample characteristics
In South Africa, Uganda and Kenya respectively, 154,
154 and 153 participants were recruited (total N = 461).
The sample characteristics are described in Table 1. In
all three countries the majority of the sample was female
and had HIV disease.The number of participants with
both HIV and cancer (and therefore diagnosed as having
a primary HIV diagnosis) was n = 114. Household sizes
were similar, although Ugandan respondents were re-
sponsible for a greater number of children compared to
the Kenyan and South African samples. The Kenyan
sample had the best physical function and South Africa
the least, and more patients in South Africa were under
homecare compared to the other sites. These data reflect
the contextual and palliative care model differences be-
tween African countries [31].
Outcome scores
Table 2 displays the mean, standard deviation and minimum/
maximum scores for the FACIT-G Total, FACIT-PAL and
APCA African POS for the Ugandan, Kenyan and South
African samples and the results of the ANOVAs compar-
ing these across each country. Interestingly, for all three
countries the subscale “social and family wellbeing” had
the highest (best) score. There was a significant main ef-
fect for Country on the FACIT-G Total score and a post-
hoc Tukey test showed that this was due to the mean for
Uganda being significantly lower (worst) than that in both
Kenya and South Africa. Table 2 also presents the mean
scores for the Physical, Social/Family, Emotional and
Functional Well-Being subscales of the FACIT-G and the
Table 1 Sample characteristics for all three countries (n = 461)
Country Uganda (n = 154) Kenya (n = 153) South Africa (n = 154)
Mean age (sd, range) 46.25 (sd = 14.39, 19–86) 48.94 (13.02, 18–85) 45.44 (15.67, 19–94)
Gender F (%), M (%) 86 (56%), 68 (44%) 101 (66%), 52 (34%) 127 (83%), 26 (17%)
Primary HIV diagnosis Yes (%) 114 (74%) 91 (59%) 99 (65%)
Primary cancer diagnosis Yes (%) 40 (26%) 62 (41%) 55 (35%)
Household size i.e., n of people mean (standard deviation) 5.96 (4.4) 4.27 (2.25) 4.30 (2.49)
Children responsible for mean (standard deviation) 4.34 (4.03) 2.78 (2.26) 1.51 (1.54)
Functional status
• Fully active 40 (26%) 73 (48%) 17 (11%)
• Restricted 73 (47%) 46 (30%) 36 (23%)
• Ambulatory 23 (15%) 25 (16%) 34 (22%)
• Limited self care 11 (7%) 7 (5%) 60 (39%)
• Completely disabled 7 (4.5%) 2 (1%) 5 (3%)
• Missing - - 1
Place of care
• Home 11 (7%) 1 (1%) 137 (89%)
• Inpatient 7 (4.5%) - 1
• Day care 45 (29%) 43 (28%) -
• Outpatient 61 (40%) 109 (71%) -
• Other 30 (19.5%) - 14 (9%)
• Missing - - 2
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was a main effect for Country on Personal, Emotional and
Family Well-Being and again post-hoc tests showed that
this was explained by the mean values in Uganda being sig-
nificantly lower (worse) than those in both other countries.
Missing data were relatively infrequent across all threeTable 2 Descriptive statistics comparing FACIT-G (total, subsc
countries with Cronbach’s α for all Scales
Country Uganda (n = 154)
Mean (s.d., min-max) Me
FACIT-G subscale: Physical
well-being Poss range 0-28
14.95 (6.84, 0–28) α = 0.81 17.63
FACIT-G subscale: Social family
well-being Poss range 0-28
18.78 (7.08, 0–28) α = 0.77 22.91
FACIT-G subscale: Emotional
well-being Poss range 0-24
17.45 (6.50, 0–24) α = 0.83 18.95
FACIT-G subscale: Functional
well-being Poss range 0-28
15.75 (7.64, 1–28) α = 0.86 19.17
FACIT-G Total Poss range 0-108 66.93 (21.11, 13–107) α = 0.90 78.66 (
FACIT-Pal subscale
Poss range 0-76
59.69 (11.85, 17–76) α = 0.81 62.96
FACIT-G + Pal Poss
range 0-184
126.63 (31.11, 40–181) α = 0.92 141.63
APCA African POS Total
Poss range 0-35
11.93 (6.83, 0–29) α = 0.72 11.98
Higher FACIT-Pal score means better quality of life, lower POS score means better pquestionnaires. There were zero missing data points for
the seven items of the African POS. For the 17 items of
the Pal subscale of the FACT-Pal, missing data ranged
from 2–4 data points. For the 27 FACT-G items, only four
items had more than four participants with missing data:
these were I am satisfied with my sex life (40), My workales and ‘Pal’) and APCA African POS across three
Kenya (n = 153) South Africa (n = 154) F P=
an (s.d., min-max) Mean (s.d., min-max)
(8.00, 0–28) α = 0.86 19.74 (6.44, 2–28) α = 0.78 17.204 0.001
(5.53, 5–28) α = 0.77 21.39 (6.12, 3–28) α = 0.78 17.101 0.001
(5.70, 3–25) α = 0.81 18.01 (5.62, 4–24) α = 77 2.503 0.083
(7.48, 1–28) α = 0.88 19.06 (6.48, 1–28) α = 0.84 10.951 0.001
20.14, 18–108) α = 0.91 78.12 (17.05, 20–108) α = 0.88 17.635 0.001
(10.66,22-76 ) α = 0.83 60.35 (10.96, 25–76) α = 0.81 3.641 0.027
(29.55, 42–184) α = 0.93 139.18 (26.41, 45–184) α = 0.92 11.62 0.001
(5.82, 1–26) α = 0.55 10.93 (6.55, 0–32) α = 0.55 1.312 0.270
roblem intensity.
Table 4 Univariate linear regression analyses: FACIT-G +
Pal then POS as the dependent variable.
Variable Levels Model F R2 p
Dependent: FACT-G + Pal
Age 3 0.64 0.53 0.00
Gender 2 0.17 0.68 0.00
Country 3 11.62 0.001 0.05
HIV diagnosis 2 1.05 0.31 0.00
Functional status 5 16.55 0.001 0.13
Dependent: POS
Age 3 1.62 0.20 0.01
Gender 2 0.44 0.56 0.00
Country 3 1.31 0.27 0.01
HIV diagnosis 2 0.03 0.87 0.00
Functional status 5 5.15 0.01 0.04
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partner (or person who is my main support) (13), and I am
able to work (including work at home) (6).
Table 3 reports the results of the t-test comparisons
for gender and diagnosis, showing there were no signifi-
cant differences across these variables.
For the univariate regression analyses, only Country and
Functional Status accounted for significant variance in the
FACIT-G + Pal, with Functional Status accounting for 13%
and Country 5% of variance (see Table 4). In the multiple
regression analysis these two variables entered together
accounted for 21% of overall variance in FACIT-G + Pal
scores (see Table 5). Compared to those with best func-
tional status (i.e., “fully active”) each level of worsening
functional status was associated with worsening FACIT-G+
Pal score.
For the univariate regression analyses with POS as
dependent variable (see Table 4), only functional status
was significant (accounting for 4% of variance), although
we also retained country in the multivariable model due
to earlier evidence of country effect. In the final multivari-
able model (see Table 5, 7% of variance accounted for),
compared to those with best functional status (i.e. “fully
active”) each level of worsening functional status was asso-
ciated with worse POS score. Compared to South Africa,
Ugandan participants had a worse score, and Kenyans had
a slightly poorer score.
The matrix of correlational coefficients (see Table 6) re-
vealed a moderate correlation between the APCA African
POS and the FACIT-Pal (0.60), the FACIT-G and the
APCA African POS (0.64), and the FACIT-G + Pal with
the POS (0.66).Table 3 Results of t-tests comparing gender and primary diag
Measure Mean (SD)
FACIT-G Males (n = 146)
Females (n = 311)
FACIT-Pal Males (n = 145)
Females (n = 304)
FACIT-G + Pal Males (n = 145)
Females (n = 303)
APCA African POS Males (n = 146)
Females (n = 314)
FACIT-G HIV (n = 302)
Cancer (n = 124)
FACIT-Pal subscale HIV (n = 296)
Cancer (n = 123)
FACIT-G + Pal HIV (n = 295)
Cancer (n = 123
APCA African POS HIV (n = 304)
Cancer (n = 124)Discussion
These data are the first to provide self-report data
using measures of multi-dimensional wellbeing mea-
sures specifically designed for patients with progres-
sive illness across diagnoses, and was conducted in three
African countries.
Our samples were relatively young which reflects the HIV
population, and are therefore responsible for children. This
has important implications for palliative care provision, as
hospice and palliative care aims to provide family-based
support. They also had relatively high physical function,
which reflects the African model of palliative care integra-
tion throughout the HIV disease trajectory [9].nosis on outcome scores for combined three countries
t (df) P =
73.12 (20.35) −1.059 (455) 0.29
75.26 (20.17)
61.71 (11.38) 0.889 (447) 0.37
60.70 (11.19)
134.92 (30.15) −.41 (446) 0.68
136.16 (29.75)
11.30 (6.45) −0.662 (458) 0.51
11.73 (6.40)
75.26 (21.51) 1.384 (424) 0.17
72.22 (18.06)
61.14 (11.31) 0.178 (417) 0.86
60.93 (10.95)
136.55 (31.42) 1.02 (416) 0.31
133.24 (27.04)
11.70 (6.56) −0.158 (426) 0.87
11.80 (6.00)
Table 5 Multiple regression analyses: FACIT-G + Pal then POS as the dependent variable
Dependent: FACIT-G + −Pal
Parameter N B Std. error t P value 95% Confidence interval for B
Lower bound Upper bound
ECOG:
Completely disabled 14 −37.90 7.74 −4.90 .001 −53.12 −22.70
Limited self-care 77 −30.68 4.45 −6.90 .001 −39.42 −21.94
Ambulatory 82 −22.32 3.99 −5.60 .001 −30.16 −14.48
Restricted 154 −21.69 3.33 −6.51 .001 −28.23 −15.14
Fully active 130 Ref Ref Ref Ref Ref Ref
Country:
Uganda 154 −18.50 3.45 −5.36 .001 −25.27 −11.71
Kenya 153 −8.95 3.55 −2.52 .01 −15.94 −1.97
South Africa (reference group) 150 Ref Ref Ref Ref Ref Ref
Dependent: POS
N B Std. error t P value 95% Confidence interval for B
Lower bound Upper bound
ECOG:
Completely disabled 14 3.85 1.77 2.16 0.03 0.35 7.34
Limited self-care 77 4.64 1.00 4.61 0.00 2.67 6.63
Ambulatory 82 3.95 0.91 4.36 1 2.17 5.74
Restricted 154 3.20 0.76 4.20 0.00 1.70 4.70
Fully active (reference group) 130 Ref Ref Ref 1 0.00 1 Ref Ref Ref
Country:
Uganda 154 1.98 0.77 2.55 0.01 0.45 3.51
Kenya 153 2.78 0.83 3.46 0.00 1.20 4.36
South Africa (reference group) 150 Ref Ref Ref 1 Ref Ref Ref
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to be best for the social/family wellbeing dimension. This
reflects both the data on number of children patients were
responsible for, but may also reflect African cultures which
are more communal and less individualistic than Western
societies, therefore support may have been accessed in the
community. Poverty also appears to be an important fac-
tor in our sample, as the Ugandan sample had worse
scores on most outcomes than respondents in Kenya and
South Africa, and Uganda has a lower gross domestic
product (GDP) than the other countries. Importantly, no
difference in total scores was found when comparing HIV
and cancer patients, which suggests that services can ap-
proach both populations with a similar care and thus
avoid the “silo” approach of providing separate oncology
and HIV palliative care services. Importantly, physical
function was strongly associated with worse status for
both outcome measures (FACT-G + Pal and POS). The
role of rehabilitation is key for patients with progressive
illness, as function can be maximised within palliative care
planning [32,33]. The worse total scores for Ugandanpatients in multivariable analysis may also reflect the refer-
ral criteria across countries, in that the Ugandan service
may assume care for those with greatest need.
In terms of the comparison of measures we note a statis-
tically significant, moderate correlation between the POS
and APCA African POS/FACIT dimensions, suggesting
that these two tools measure related but conceptually dis-
tinct aspects of wellbeing. The FACT-G + Pal is slightly
more strongly correlated to the POS that the Pal dimen-
sion alone, suggesting that the FACT-G also supports the
measurement of outcomes for advanced disease, and that
the Pal should be used with FACT-G and not alone.
There are a number of limitations to our study. Firstly we
note that the APCA African POS is the only measure that
has been fully validated for use with palliative care popula-
tions in sub-Saharan Africa, although the FACT-Pal has
undergone rigorous translation. We also assume equiva-
lence between the tools in the different languages, al-
though there may be conceptual differences related to
language and culture. There may be a sampling bias that
have led to an underestimation of problems, as palliative












Personal well-being r = .809
p < .000
n = 458
Social well-being r = .577 .207
p < .000 .000
n = 458 460
Emotional well-being r = .727 .482 .259
p < .000 .000 .000
n = 458 459 459
Family well-being r = .836 .652 .290 .478
p < .000 .000 .000 .000
n = 458 458 458 458
FACIT-Pal subscale r = .774 .589 .470 .602 .641
p < .000 .000 .000 .000 .000
n = 449 449 449 449 450
APCA African POS r = -.636 -.574 -.315 -.517 -.472 -.605
p < .000 .000 .000 .000 .000 .000
n = 458 460 460 459 459 450
FACIT-G + Pal r = .971 .777 .570 .772 .810 .903 −0.663
Total score p < .000 .000 .000 .000 .000 .000 .000
n= 449. 449 449 449 449 449 449
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tems [34], and therefore those who have not entered hos-
pice or palliative care may have worse problems. Lastly
our cross sectional design can identify associations but
not causality.
Conclusions
The care of those with life limiting, progressive illness
within low and middle income settings requires appro-
priate care to ensure optimal quality of life, minimal
suffering and a good death. Our data reveal across all
countries that family and social wellbeing were the worst
problems, which is consistent with cultures with more
communal rather than individualistic characteristics. Im-
portantly, total self-reported quality of life and palliative
care problem severity does not differ by diagnosis, suggest-
ing that separate palliative care services are not needed for
each population, although of course there may be variation
between diagnoses by item. There is a strong requirement
for clinicians to ensure that assessment and models of care
address the social dimensions of wellbeing. The clinical
presentation of problems may differ according to country,
with providers facing higher levels of patient need in
economically poorer settings. However, a common pat-
tern of worsening wellbeing was found with decliningphysical function, and maximising function within a clin-
ical approach of palliation is essential to enhance patient
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